185 related articles for article (PubMed ID: 16632481)
1. Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritis.
Koivula MK; Aman S; Alasaarela E; Karjalainen A; Hakala M; Risteli J
Rheumatology (Oxford); 2006 Nov; 45(11):1364-9. PubMed ID: 16632481
[TBL] [Abstract][Full Text] [Related]
2. Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?
Koivula MK; Aman S; Karjalainen A; Hakala M; Risteli J
Ann Rheum Dis; 2005 Oct; 64(10):1443-50. PubMed ID: 16162901
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity and specificity of autoantibodies binding to citrullinated carboxyterminal telopeptides of types I and II collagens in an early arthritis series.
Koivula MK; Savolainen E; Kaipiainen-Seppänen O; Kautiainen H; Luosujärvi R; Hakala M; Risteli J
Rheumatology (Oxford); 2008 May; 47(5):656-9. PubMed ID: 18356174
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis.
Koivula MK; Heliövaara M; Ramberg J; Knekt P; Rissanen H; Palosuo T; Risteli J
Ann Rheum Dis; 2007 Nov; 66(11):1450-5. PubMed ID: 17472989
[TBL] [Abstract][Full Text] [Related]
5. Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis.
Koivula MK; Heliövaara M; Rissanen H; Palosuo T; Knekt P; Immonen H; Risteli J
Ann Rheum Dis; 2012 Oct; 71(10):1666-70. PubMed ID: 22419777
[TBL] [Abstract][Full Text] [Related]
6. Sensitive immunoassays for the autoantibodies reacting against citrullinated carboxy-terminal telopeptides of type I and type II collagens in patients with rheumatoid arthritis.
Koivula MK; Ramberg J; Aman S; Karjalainen A; Hakala M; Risteli J
Clin Chem Lab Med; 2005; 43(12):1400-5. PubMed ID: 16309380
[TBL] [Abstract][Full Text] [Related]
7. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
[TBL] [Abstract][Full Text] [Related]
8. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
Charni N; Juillet F; Garnero P
Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
[TBL] [Abstract][Full Text] [Related]
9. [Significance of citrullinated collagen type II and its antibodies in rheumatoid arthritis].
Tian X; Bi LQ; Li ZG
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(33):2334-8. PubMed ID: 17156630
[TBL] [Abstract][Full Text] [Related]
10. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse.
Burkhardt H; Koller T; Engström A; Nandakumar KS; Turnay J; Kraetsch HG; Kalden JR; Holmdahl R
Arthritis Rheum; 2002 Sep; 46(9):2339-48. PubMed ID: 12355481
[TBL] [Abstract][Full Text] [Related]
11. Serum autoantibodies that bind citrullinated fibrinogen are frequently found in patients with rheumatoid arthritis.
Hill JA; Al-Bishri J; Gladman DD; Cairns E; Bell DA
J Rheumatol; 2006 Nov; 33(11):2115-9. PubMed ID: 16924693
[TBL] [Abstract][Full Text] [Related]
12. Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis.
Montano-Loza A; Czaja AJ; Carpenter HA; Piette A; Murphy D; Shums Z; Burlingame R; Norman GL
Autoimmunity; 2006 Jun; 39(4):341-8. PubMed ID: 16891223
[TBL] [Abstract][Full Text] [Related]
13. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
14. Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis.
Suzuki A; Yamada R; Ohtake-Yamanaka M; Okazaki Y; Sawada T; Yamamoto K
Biochem Biophys Res Commun; 2005 Jul; 333(2):418-26. PubMed ID: 15950180
[TBL] [Abstract][Full Text] [Related]
15. Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis.
Fusconi M; Vannini A; Dall'Aglio AC; Pappas G; Cassani F; Ballardini G; Frisoni M; Grassi A; Bianchi FB; Zauli D
Aliment Pharmacol Ther; 2005 Nov; 22(10):951-5. PubMed ID: 16268969
[TBL] [Abstract][Full Text] [Related]
16. Separate and overlapping specificities in rheumatoid arthritis antibodies binding to citrulline- and homocitrulline-containing peptides related to type I and II collagen telopeptides.
Turunen S; Hannonen P; Koivula MK; Risteli L; Risteli J
Arthritis Res Ther; 2015 Jan; 17(1):2. PubMed ID: 25573503
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
18. IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA.
Engelmann R; Brandt J; Eggert M; Karberg K; Krause A; Neeck G; Mueller-Hilke B
Rheumatology (Oxford); 2008 Oct; 47(10):1489-92. PubMed ID: 18703528
[TBL] [Abstract][Full Text] [Related]
19. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis.
Burkhardt H; Sehnert B; Bockermann R; Engström A; Kalden JR; Holmdahl R
Eur J Immunol; 2005 May; 35(5):1643-52. PubMed ID: 15832289
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]